21 CFR 520.1705
§ 520.1705 Pergolide.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 520.1705, § 520.1705 Pergolide, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87264
- Permanent ID
ys:prov:87264@1- SHA-256
c43077b79a2171a9f4300e9230ed26b50dd771f4d886aea08c2afdae4211209c
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each tablet contains 1 milligram (mg) pergolide (as pergolide mesylate).
(b) Sponsor. See Nos. 000010 and 017033 in § 510.600(c) of this chapter.
(c) Conditions of use in horses—(1) Amount. Administer orally at a starting dose of 2 micrograms/kilograms (µ/kg) once daily. Dosage may be adjusted to effect, not to exceed 4 µg/kg daily.
(2) Indications for use. For the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing's Disease).
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.